Menu
Back to Journals » Drug Design, Development and Therapy » Volume 9
Review
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 67,897 | Dovepress* | 40,607+ | 4,150 | 44,757 | |
| PubMed Central* | 27,290 | 5,692 | 32,982 | ||
| Totals | 67,897 | 9,842 | 77,739 | ||
|
*Since 10 August 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 15 | 0 | 0 | 0 | 1 | 14 |
View citations on PubMed Central and Google Scholar